These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1623817)

  • 21. [Oral contraceptives and cancer].
    La Vecchia C
    Minerva Ginecol; 2006 Jun; 58(3):209-14. PubMed ID: 16783292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer and hormone exposure.
    Szarewski A; Guillebaud J
    Lancet; 1996 Sep; 348(9028):682-3. PubMed ID: 8782769
    [No Abstract]   [Full Text] [Related]  

  • 23. [Breast cancer and the use of hormones around menopause].
    Boukes FS; Groeneveld FP; Goudswaard AN
    Ned Tijdschr Geneeskd; 2004 Jun; 148(23):1170. PubMed ID: 15211974
    [No Abstract]   [Full Text] [Related]  

  • 24. Breast cancer and hormone exposure.
    Grant EC; Antony HM; Myhill S; Price EH; Steel CM
    Lancet; 1996 Sep; 348(9028):682; author reply 683. PubMed ID: 8782768
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
    Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cancers and contraceptive pill: the CNGOF, the FNCGM and the SFG answer the CIRC].
    Serfaty D; Boutet G; Lansac J; Lopès P
    Gynecol Obstet Fertil; 2006 Feb; 34(2):92-3. PubMed ID: 16497533
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current aspects of hormonal contraception].
    Lauritzen C
    Krankenpfl J; 1989 Oct; 27(10):9-18. PubMed ID: 2586085
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of hormone-replacement therapy and steroid contraceptives in menopause as an oncological and epidemiological problem: is it a risk and/or benefit?].
    Bershteĭn LM
    Vopr Onkol; 2005; 51(6):636-46. PubMed ID: 17037027
    [No Abstract]   [Full Text] [Related]  

  • 29. Breast cancer and oral contraceptives: critique of the proposition that high potency progestogen products confer excess risk.
    Sturtevant FM
    Biomed Pharmacother; 1984; 38(8):371-9. PubMed ID: 6525434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oral contraceptives and breast cancer].
    Zoricić D; Ambrozić B; Perić D
    Lijec Vjesn; 1998 Dec; 120(12):392-7. PubMed ID: 19658362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral contraceptives and breast cancer.
    Asscher AW
    Br Med J (Clin Res Ed); 1987 Nov; 295(6610):1418. PubMed ID: 3121046
    [No Abstract]   [Full Text] [Related]  

  • 32. [Etiology and pathogenesis of neoplasms and dysplasia of the breast].
    Stefanini P
    Minerva Chir; 1976 Nov; 31(22):1275-80. PubMed ID: 1012542
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral contraceptives and breast cancer.
    Asscher AW
    Lancet; 1987 Nov; 2(8570):1267. PubMed ID: 2890873
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral contraceptives and breast cancer.
    Armstrong BK
    Lancet; 1986 Mar; 1(8480):552-3. PubMed ID: 2869274
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral contraceptive use during the perimenopausal years.
    Van Winter JT; Bernard ME
    Am Fam Physician; 1998 Oct; 58(6):1373-7, 1381-2. PubMed ID: 9803201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oral contraceptives and oral candidiasis].
    Krekeler G; Ochs G; Haderthauer W
    Fortschr Med; 1981 Feb; 99(7):230-2. PubMed ID: 7216106
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of administration of hormonal contraceptives on prognostic factors in breast cancer].
    Schönborn I; Ebeling K
    Zentralbl Gynakol; 1990; 112(5):263-6. PubMed ID: 2162121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Challenges for the current oral hormonal contraception when applied to women with increased risk for ovarian and breast malignancies].
    Usunova I
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():46-7. PubMed ID: 19504708
    [No Abstract]   [Full Text] [Related]  

  • 39. [Contraception and breast cancer].
    Kottler ML; Gorins A
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):21-6. PubMed ID: 2068480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
    Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
    Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.